SV

Srinivasan Visalakshi

Active Director Director DIN 03549437
DIN 03549437 First appointment Jul 2011 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 2 historical roles
Total affiliations 4 Since Jul 2011
Shareholding value •••• Premium profile

About Srinivasan Visalakshi

Data last updated:

Srinivasan Visalakshi is a Director at Meenakshi Medical Distributors Private Limited (since 2011) and Additional Director at Forecare Pharmaceuticals Private Limited (since 2015). The companies operate in Pharma and Construction. The 2 current companies with reported revenue have a combined latest revenue of ₹46.19 Cr; the largest is Meenakshi Medical Distributors Private Limited at ₹45.21 Cr (FY 2024). Earlier, Srinivasan Visalakshi was a Director at Sree Kamalam Property Developer Private Limited (2021–2023) and Director at Huma Biotechnologies Private Limited (from 2016).

DIN 03549437
Primary Designation Director
Industry Pharma
First Appointment 15 Jul 2011
Oldest Company Age 15 yrs
Largest company Meenakshi Medical Distributors Private Limited · ₹45.21 Cr (FY 2024)
Combined revenue ₹46.19 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Jul 20112011₹45.21 Cr (FY 2024)Active
Additional Director03 Jun 20152015₹97.8 Lakh (FY 2018)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Apr 20212021₹3.3 Lakh (FY 2025)Active
Huma Biotechnologies Private Limited U33209TN2016PTC110533
Director24 May 20162016₹13.8 Lakh (FY 2018)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Forecare Pharmaceuticals Private Limited
Huma Biotechnologies Private Limited
Meenakshi Medical Distributors Private Limited
Sree Kamalam Property Developer Private Limited
Premium access

Shareholding and investment profile for Srinivasan Visalakshi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srinivasan Visalakshi

Srinivasan Visalakshi currently holds 2 directorships: Meenakshi Medical Distributors Private Limited (Director, since 15 Jul 2011, revenue ₹45.21 Cr (FY 2024)); Forecare Pharmaceuticals Private Limited (Additional Director, since 03 Jun 2015, revenue ₹97.8 Lakh (FY 2018)).

Srinivasan Visalakshi was first appointed on 15 Jul 2011 as Director at Meenakshi Medical Distributors Private Limited. The most recent appointment on record is 10 Apr 2021 at Sree Kamalam Property Developer Private Limited.

The 2 current companies of Srinivasan Visalakshi that report revenue have a combined latest revenue of ₹46.19 Cr: Meenakshi Medical Distributors Private Limited ₹45.21 Cr (FY 2024); Forecare Pharmaceuticals Private Limited ₹97.8 Lakh (FY 2018).

Srinivasan Visalakshi held 2 earlier board appointments: Sree Kamalam Property Developer Private Limited (Director, 10 Apr 2021 to 13 Jul 2023); Huma Biotechnologies Private Limited (Director, from 24 May 2016).

The current boards of Srinivasan Visalakshi's companies include Kasilingam (Meenakshi Medical Distributors Private Limited), Meenakshi (Meenakshi Medical Distributors Private Limited), Peryasamy (Meenakshi Medical Distributors Private Limited), Rajendran Sathya Devi (Meenakshi Medical Distributors Private Limited), Arumugam Pillai Tamilselvan (Forecare Pharmaceuticals Private Limited), Kalairajan Kalaiyappan (Forecare Pharmaceuticals Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available